House Bill 4627, sponsored by Del. Brandon Steele (R), legislation that would limit medical marijuana testing to two companies passed the chamber by a vote of 67-33.
The bill would limit medical marijuana testing to just two companies will now be considered by the Senate, reported The Center Square.
The bill seeks to amend and reenact state legislation to provide for no more than two licensed laboratories for medical cannabis testing.
The proposed amendment establishes that growers and processors shall contract with an independent laboratory to test the medical cannabis they produce. Laboratories will be accountable to the state’s Bureau for Public Health.
“The bureau shall ensure that there is sufficient testing capacity to meet patient demand. All laboratories providing testing pursuant to this section shall be certified to do so by the Office of Laboratory Services: Provided, That no more than two laboratories in this state may be certified pursuant to this section,” states the legislation.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
